Egg Supplementation for Infant Cognitive Development During Breastfeeding
(ICAN Trial)
Trial Summary
What is the purpose of this trial?
Purpose: To establish a whole food, egg, as a viable study material to supplement mothers and infants with nutrients that support optimal brain development. There will be 84 breastfeeding dyads, 3 months postnatal. Mothers will be randomized to a whole egg or egg white (due to lack of an appropriate control food). Initial diet intake will be screened using the NDSR. Participants will come to the lab 3 times across 3 months (age 3 months, 4.5 months, and 6 months). Milk, saliva, and plasma will be collected from the mother, while saliva and plasma (heel stick) are collected from the infant. Diet data will be collected at each visit. The infant will complete a recognition memory test using electrophysiology at 6 months as well as the Bayley Scales of Infant Development at 4.5 months. The mother will complete a temperament questionnaire at 3 months and 6 months.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Egg White Powder, Egg White Protein Powder, Albumen Powder, Whole Egg Powder, Whole Egg Powder, Egg Powder, Dehydrated Egg for infant cognitive development during breastfeeding?
The research on egg white products shows that they can enhance resistance to infections in mice, suggesting potential health benefits. Additionally, egg white powder is used for protein supplementation in critically ill patients, indicating its nutritional value, which might support infant development.12345
Is egg supplementation safe for humans?
How does egg supplementation during breastfeeding differ from other treatments for infant cognitive development?
Egg supplementation during breastfeeding is unique because it uses egg white and whole egg powders, which are rich in essential amino acids and nutrients that may support cognitive development. Unlike other treatments, this approach focuses on natural food sources rather than synthetic supplements or drugs.3891011
Research Team
Carol L Cheatham, Ph.D.
Principal Investigator
Associate Professor, University of North Carolina-Chapel Hill
Eligibility Criteria
This trial is for healthy breastfeeding mothers aged 18-35, who gave birth at full term without complications and whose infants are 12-15 weeks old. Participants must be consuming less than half the recommended amounts of DHA, choline, or lutein. Those with egg allergies or a family history of it, gestational diabetes, or infants suspected of developmental delays cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Mothers are randomized to receive either whole egg or egg white powder, with diet intake screened using the NDSR. Milk, saliva, and plasma samples are collected from mothers and infants at 3, 4.5, and 6 months.
Assessment
Infants complete a recognition memory test using electrophysiology at 6 months and the Bayley Scales of Infant Development at 4.5 months. Mothers complete a temperament questionnaire at 3 and 6 months.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Egg White Powder
- Whole Egg Powder
Egg White Powder is already approved in United States, European Union, Canada for the following indications:
- General nutritional supplement
- Food ingredient
- General nutritional supplement
- Food ingredient
- General nutritional supplement
- Food ingredient
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Egg Nutrition Center
Collaborator